Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Gastroenterology. 2016 Sep 28;152(1):206–217.e2. doi: 10.1053/j.gastro.2016.09.032

Table 1.

Genome Wide Significant Associations and Maximal Established Loci Replications

Genome Wide Significant Associations and Established Loci Replications for UC, CD and IBD. The 1000Genomes Project phase 3 allele frequencies for various populations is included.

Phenotyp
e
Chr Position A1 A2 SNP Name GWAS1 (Omni2.5) GWAS2 (Axiom) Meta-analysis Nearest Gene(s) Annotatio
n
Significance
Level
MAF
(Minor
Allele)
African Sub-populations
with highest MAF


P-Value Case
Freq
Control
Freq
OR 95% CI P-Value Case
Freq
Control
Freq
OR 95% CI OR P-value YRI EAS EUR SAS
UC 6 32559063 A C rs9270484 1.45E-07 0.448 0.356 0.68 0.58 – 0.8 4.41E-07 0.426 0.319 0.63 0.52 – 0.76 0.58 3.22E-12 HLA-DRB1 intergenic GWS 0.11 (C) 0.31 (C) 0.31 (C) 0.3 (C)
6 32557435 A C rs9270299 5.98E-08 0.284 0.207 0.66 0.55 – 0.79 1.06E-05 0.281 0.209 0.68 0.55 – 0.83 0.52 2.65E-11 HLA-DRB1 exonic GWS 0.15 (A) 0.16 (A) 0.12 (A) 0.24 (A)
6 32552617 G A rs28724138 4.62E-07 0.412 0.487 0.74 0.62 – 0.87 2.75E-06 0.572 0.482 0.70 0.58 – 0.84 0.57 4.70E-11 HLA-DRB1 intronic GWS 50 (A) 47 (A) 47 (G) 49 (A)
19 52400451 G A rs78090981 * 9.65E-06 0.054 0.026 2.16 1.46 – 3.21 1.54E-05 0.051 0.022 2.42 1.55 – 3.78 3.64 9.93E-10 ZNF649 intronic GWS 0.06 (A) 0 (A) 0 (A) 0 (A) YRI - 0.06 (A)
3 115528296 C T rs72947885 * 5.19E-08 0.099 0.054 1.91 1.43 – 2.56 8.07E-03 0.080 0.051 1.62 1.14 – 2.3 2.42 4.48E-09 LSAMP UTR3 GWS 0.07 (T) 0 (T) 0 (T) 0 (T) LWK - 0.12 (T)
20 62100266 T G rs914467 1.72E-02 0.101 0.071 1.46 1.11 1.93 1.23E-06 0.140 0.093 1.59 1.21 – 2.09 1.97 5.91E-07 KCNQ2 intronic Locus Replication 0.02 (G) 0.15 (G) 0.24 (G) 0.14 (G)
9 117811778 C T rs114032850 * 4.04E-05 0.078 0.042 1.91 1.38 2.64 1.78E-02 0.065 0.041 1.61 1.1 – 2.38 2.06 3.68E-06 TNC intronic 0.06 (T) 0 (T) 0 (T) 0 (T) MAG - 0.09 (T)
3 101641101 A T rs141365838 4.72E-02 0.111 0.082 1.39 1.06 1.81 2.55E-06 0.166 0.106 1.68 1.3 – 2.17 1.67 3.90E-06 NFKBIZ intergenic 0.1 (T) 0.1 (T) 0.22 (T) 0.2 (T)
20 62308570 A G rs2738782 6.15E-06 0.152 0.099 0.61 0.48 0.78 7.20E-01 0.162 0.167 1.03 0.8 – 1.33 0.45 8.21E-06 RTEL1:TNFRSF6B intronic 0.05 (A) 0.42 (G) 0.41 (A) 0.37 (A)

CD 16 50709723 G A rs6596 3.55E-05 0.058 0.032 1.91 1.42 2.56 3.14E-04 0.062 0.049 1.28 1 – 1.64 2.06 1.14E-07 SNX20 exonic Locus Replication 0 (A) 0 (A) 0.16 (A) 0.01 (A)
5 40424426 A C rs6896969 5.46E-04 0.333 0.387 1.26 1.11 1.44 4.22E-05 0.330 0.391 1.30 1.15 – 1.47 1.28 1.69E-07 PTGER4 intergenic Locus Replication 0.38 (A) 0.14 (C) 0.41 (A) 0.45 (C)
1 67665210 A G rs1569923 2.91E-05 0.434 0.362 0.74 0.65 0.84 8.37E-04 0.425 0.389 0.86 0.76 – 0.97 0.78 1.88E-07 IL23R intronic Locus Replication 0.36 (A) 0.39 (G) 0.37 (G) 0.37 (G)
21 16799818 G A rs7276764 7.76E-03 0.277 0.314 0.84 0.73 0.96 3.01E-05 0.276 0.320 0.81 0.71 – 0.92 0.76 2.59E-06 USP25 intergenic 0.34 (A) 0.24 (A) 0.29 (A) 0.23 (A)
2 25145173 T A rs59086897 9.54E-03 0.192 0.204 1.08 0.92 1.26 4.54E-05 0.199 0.259 1.41 1.22 – 1.63 1.33 4.00E-06 ADCY3 intergenic 0.08 (T) 0.44 (A) 0.47 (A) 0.48 (A)
6 167541624 T C rs41414848 * 2.88E-02 0.069 0.089 0.76 0.6 0.96 7.09E-06 0.040 0.068 0.58 0.44 – 0.77 0.64 4.42E-06 CCR6 intronic 0.09 (C) 0 (C) 0 (C) 0 (C) ESN - 0.12 (C)
4 106934908 C A rs6854424 * 3.60E-05 0.055 0.033 1.71 1.27 2.3 2.75E-02 0.041 0.028 1.47 1.08 – 1.99 1.85 5.86E-06 TBCK intronic 0.04 (A) 0 (A) 0 (A) 0 (A) MAG / MSL - 0.06 (A)

IBD 21 16800087 C T rs7278277 1.60E-04 0.530 0.473 0.80 0.71 – 0.89 1.21E-05 0.513 0.476 0.86 0.78 – 0.96 0.77 1.99E-08 USP25 intergenic GWS 0.43 (C) 0.24 (T) 0.29 (T) 0.23 (T)
5 40424426 A C rs6896969 4.09E-04 0.340 0.387 1.22 1.09 – 1.37 2.85E-05 0.335 0.391 1.27 1.14 – 1.42 1.25 7.81E-08 PTGER4 intergenic Locus Replication 0.38 (A) 0.14 (C) 0.41 (A) 0.45 (C)
6 32594240 T A rs139282044 * 5.48E-05 0.050 0.031 1.67 1.26 2.21 1.74E-04 0.038 0.022 1.76 1.31 – 2.36 1.93 9.43E-08 HLA-DQA1 intergenic Locus Replication 0.04 (A) 0 (A) 0 (A) 0 (A) ESN - 0.08 (A)
9 117811778 C T rs114032850 * 3.14E-05 0.066 0.042 1.61 1.26 2.05 4.00E-04 0.063 0.041 1.56 1.24 – 1.95 1.65 9.59E-08 TNC intronic Locus Replication 0.06 (T) 0 (T) 0 (T) 0 (T) MAG - 0.09 (T)
5 158782684 C T rs11749526 3.20E-05 0.020 0.034 0.58 0.41 0.83 9.64E-04 0.023 0.042 0.54 0.39 – 0.75 0.53 2.64E-07 LOC285626: IL12B intronic Locus Replication 0 (T) 0.08 (T) 0.14 (T) 0.05 (T)
3 45989578 C G rs55698153 * 1.82E-05 0.050 0.075 0.64 0.51 0.81 7.67E-03 0.037 0.049 0.75 0.57 – 0.98 0.60 6.94E-07 CXCR6 UTR3 Locus Replication 0.06 (G) 0 (G) 0 (G) 0 (G) YRI / ESN / LWK - 0.06 (G)
2 25145173 T A rs59086897 3.58E-03 0.191 0.204 1.09 0.95 – 1.25 3.72E-05 0.204 0.259 1.36 1.2 – 1.55 1.31 1.18E-06 ADCY3 intergenic Locus Replication 0.08 (T) 0.44 (A) 0.47 (A) 0.48 (A)
1 67630341 A T rs10889663 8.74E-03 0.299 0.331 0.86 0.77 – 0.97 3.46E-05 0.274 0.313 0.83 0.74 – 0.93 0.78 2.60E-06 IL23R intergenic Observed variant without frequency or population information
6 167541624 T C rs41414848 * 4.04E-02 0.071 0.089 0.78 0.64 0.96 1.50E-06 0.042 0.068 0.61 0.48 – 0.78 0.67 3.50E-06 CCR6 intronic 0.09 (C) 0 (C) 0 (C) 0 (C) ESN - 0.12 (C)
1 120553996 C T rs7530844 3.63E-05 0.215 0.157 1.47 1.27 1.69 1.61E-02 0.230 0.233 0.99 0.87 – 1.12 1.33 8.32E-06 NOTCH2 intronic 0.02 (T) 0.23 (C) 0.18 (C) 0.4 (C)
5 150596303 C T rs13359932 1.01E-05 0.230 0.288 0.74 0.65 0.84 5.00E-02 0.238 0.248 0.95 0.84 – 1.07 0.80 9.06E-06 CCDC69 intronic 0.31 (T) 0 (T) 0.01 (T) 0 (T)

Top associations per locus for UC, CD and IBD. The top 3 HLA associations are shown for illustrative purposes.

Chr: Chromosome; A1: tested allele; A2: Alternate allele; Freq: Tested allele frequency; OR: odds ratio; CI: Confidence interval; GWS: Genome-wide significant; MAF: Minor Allele Frequency.

"Locus replication" defined as p<1.5×10−6 at SNP within 250 kb of a maximal association of a previously established locus.

YRI: Yoruba in Ibadan, Nigeria; EAS: East Asian; EUR: European; SAS: South Asian; LWK: Luhya in Webuye, in Kenya; MAG: Mandinka in Gambia; ESN: Esan in Nigeria; MSL: Mende in Sierra Leone; (data from 1000 genome phase 3)

*

African Specific SNP (monomorphic in EAS, EUR ans SAS)